To test these hypotheses, Ace-1-Dkk-1, a canine PCa overexpressing human Dkk-1 previously developed in our laboratory, was used to elucidate the molecular role of Wnt signaling and Dkk-1 in canine PCa growth and bone tumor phenotype and growth. The gene discussed is DKK1; the disease is bone neoplasm.